Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Clinical trial NCT07220408 · RECRUITING
Trial details
- NCT number
- NCT07220408
- Sponsor
- Telios Pharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-23
- Primary completion
- 2026-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.